These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 19302014)

  • 1. DAS181 and H5N1 virus infection.
    Zhang H
    J Infect Dis; 2009 Apr; 199(8):1250, author reply 1250-1. PubMed ID: 19302014
    [No Abstract]   [Full Text] [Related]  

  • 2. An investigational antiviral drug, DAS181, effectively inhibits replication of zoonotic influenza A virus subtype H7N9 and protects mice from lethality.
    Marjuki H; Mishin VP; Chesnokov AP; De La Cruz JA; Fry AM; Villanueva J; Gubareva LV
    J Infect Dis; 2014 Aug; 210(3):435-40. PubMed ID: 24569063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiviral etiotropic chemicals: efficacy against influenza A viruses A subtype H5N1].
    Leneva IA; Shuster AM
    Vopr Virusol; 2006; 51(5):4-7. PubMed ID: 17087058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of therapeutic and protective effect of Reaferon-ES Lipint on mice infected with avian influenza virus (subtype H5N1)].
    Demina OK; Sergeev AA; Agafonov AP; Shikov AN; Sementsova AO; Sergeev AA; Sergeev AN; Drozdov IG
    Antibiot Khimioter; 2009; 54(9-10):27-9. PubMed ID: 20415260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy of peramivir against H5N1 highly pathogenic avian influenza viruses harboring the neuraminidase H275Y mutation.
    Kobayashi M; Kodama M; Noshi T; Yoshida R; Kanazu T; Nomura N; Soda K; Isoda N; Okamatsu M; Sakoda Y; Yamano Y; Sato A; Kida H
    Antiviral Res; 2017 Mar; 139():41-48. PubMed ID: 28012921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into inflammation and influenza.
    Simmons C; Farrar J
    N Engl J Med; 2008 Oct; 359(15):1621-3. PubMed ID: 18843127
    [No Abstract]   [Full Text] [Related]  

  • 7. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.
    Ilyushina NA; Hoffmann E; Salomon R; Webster RG; Govorkova EA
    Antivir Ther; 2007; 12(3):363-70. PubMed ID: 17591026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection.
    Belser JA; Lu X; Szretter KJ; Jin X; Aschenbrenner LM; Lee A; Hawley S; Kim DH; Malakhov MP; Yu M; Fang F; Katz JM
    J Infect Dis; 2007 Nov; 196(10):1493-9. PubMed ID: 18008229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.
    Haasbach E; Pauli EK; Spranger R; Mitzner D; Schubert U; Kircheis R; Planz O
    Antiviral Res; 2011 Sep; 91(3):304-13. PubMed ID: 21777621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of zanamivir against avian influenza A viruses that possess genes encoding H5N1 internal proteins and are pathogenic in mammals.
    Leneva IA; Goloubeva O; Fenton RJ; Tisdale M; Webster RG
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1216-24. PubMed ID: 11257037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin and oseltamivir combination therapy does not improve the effectiveness of oseltamivir alone following highly pathogenic avian H5N1 influenza virus infection in mice.
    Belser JA; Szretter KJ; Katz JM; Tumpey TM
    Virology; 2013 Apr; 439(1):42-6. PubMed ID: 23453580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolic mofetil, an alternative antiviral and immunomodulator for the highly pathogenic avian influenza H5N1 virus infection.
    Cho J; Yi H; Jang EY; Lee MS; Lee JY; Kang C; Lee CH; Kim K
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):298-304. PubMed ID: 29017920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental study of the efficiency of oxidized dextran for prevention of influenza A/H5N1.
    Shkurupy VA; Potapova OV; Sharkova TV; Troitskii AV; Gulyaeva EP; Bystrova TN; Shestopalov AM
    Bull Exp Biol Med; 2014 Nov; 158(1):112-4. PubMed ID: 25403410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DAS181 inhibits H5N1 influenza virus infection of human lung tissues.
    Chan RW; Chan MC; Wong AC; Karamanska R; Dell A; Haslam SM; Sihoe AD; Chui WH; Triana-Baltzer G; Li Q; Peiris JS; Fang F; Nicholls JM
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3935-41. PubMed ID: 19596886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell penetrable human scFv specific to middle domain of matrix protein-1 protects mice from lethal influenza.
    Dong-din-on F; Songserm T; Pissawong T; Srimanote P; Thanongsaksrikul J; Thueng-in K; Moonjit P; Lertwatcharasarakul P; Seesuay W; Chaicumpa W
    Viruses; 2015 Jan; 7(1):154-79. PubMed ID: 25594836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 14-Deoxy-11,12-didehydroandrographolide attenuates excessive inflammatory responses and protects mice lethally challenged with highly pathogenic A(H5N1) influenza viruses.
    Cai W; Chen S; Li Y; Zhang A; Zhou H; Chen H; Jin M
    Antiviral Res; 2016 Sep; 133():95-105. PubMed ID: 27476045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiviral activity of Ingavirin in experimental lethal influenza due to influenza virus B in albino mice].
    Zarubaev VV; Garshinina AV; Kalinina NA; Shtro AA; Nebol'sin VE; Kiselev OI
    Antibiot Khimioter; 2010; 55(3-4):8-11. PubMed ID: 20695201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense oligonucleotides targeting the RNA binding region of the NP gene inhibit replication of highly pathogenic avian influenza virus H5N1.
    Zhang T; Wang TC; Zhao PS; Liang M; Gao YW; Yang ST; Qin C; Wang CY; Xia XZ
    Int Immunopharmacol; 2011 Dec; 11(12):2057-61. PubMed ID: 21933722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vivo efficacy of Ingavirin against pandemic A (H1N1/09)v influenza virus].
    Shishkina LN; Nebol'sin VE; Skarnovich MO; Kabanov AS; Sergeev AA; Erdyneeva UB; Serova OA; Demina OK; Agafonov AP; Stavskiĭ EA; Drozdov IG
    Antibiot Khimioter; 2010; 55(5-6):32-5. PubMed ID: 21033472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose interferon Type I treatment is effective against H5N1 and swine-origin H1N1 influenza A viruses in vitro and in vivo.
    Haasbach E; Droebner K; Vogel AB; Planz O
    J Interferon Cytokine Res; 2011 Jun; 31(6):515-25. PubMed ID: 21323570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.